Research & Literature

[(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosis.

Lee MJ, Kim SL, Kim HI, et al.

Parkinsonism & related disorders 2015; (21(7)):704-8.

Vascular Parkinsonism: deconstructing a syndrome.

Vizcarra JA, Lang AE, Sethi KD, Espay AJ

Movement disorders : official journal of the Movement Disorder Society 2015; (30(7)):886-94 doi:10.1002/mds.26263.

Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.

van der Holst HM, van Uden IW, Tuladhar AM, et al.

Neurology 2015; (85(18)):1569-77 doi:10.1212/WNL.0000000000002082.

Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease.

Calandra-Buonaura G, Doria A, Lopane G, et al.

Journal of neurology 2016; (263(2)):250-256 doi:10.1007/s00415-015-7961-7.

Anterograde Degeneration of the Nigrostriatal Pathway Visualized by 123I-FP-CIT SPECT in a Patient With Artery of Percheron Infarction.

Nakadate M, Miyamoto N, Starkey J, et al.

Clinical nuclear medicine 2016; (41(6)):483-4 doi:10.1097/RLU.0000000000001187.

Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism.

Dunet V, Deverdun J, Charroud C, et al.

AJNR. American journal of neuroradiology 2016; (37(12)):2310-2316 doi:10.3174/ajnr.A4889.

[Possibilities of non-drug treatment for Parkinson's disease].

Pokhabov DV, Abramov VG, Pokhabov DD

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2016; (116(8)):22-29 doi:10.17116/jnevro20161168122-29.

Neuropathology of Parkinson disease.

Dickson DW

Parkinsonism & related disorders 2018; (46 Suppl 1()):S30-S33 doi:10.1016/j.parkreldis.2017.07.033.

Nonmotor Symptoms in Vascular and Other Secondary Parkinsonism.

Levin OS, Chimagomedova AS, Skripkina NA, et al.

International review of neurobiology 2017; (134()):1303-1334 doi:10.1016/bs.irn.2017.05.016.

Therapeutic Interventions for Vascular Parkinsonism: A Systematic Review and Meta-analysis.

Miguel-Puga A, Villafuerte G, Salas-Pacheco J, Arias-Carrión O

Frontiers in neurology 2017; (8()):481 doi:10.3389/fneur.2017.00481.

An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Rektor I, Bohnen NI, Korczyn AD, et al.

Parkinsonism & related disorders 2018; (49()):9-16 doi:10.1016/j.parkreldis.2017.12.030.

Improving Community Stroke Preparedness in the HHS (Hip-Hop Stroke) Randomized Clinical Trial.

Williams O, Leighton-Herrmann Quinn E, Teresi J, et al.

Stroke 2018; (49(4)):972-979 doi:10.1161/STROKEAHA.117.019861.

Therapists' perspectives on adapting the Stepping On falls prevention programme for community-dwelling stroke survivors in Singapore.

Xu T, O'loughlin K, Clemson L, et al.

Disability and rehabilitation 2019; (41(21)):2528-2537 doi:10.1080/09638288.2018.1471168.

Parkinsonism in a population-based study of individuals aged 75+ years: The Pietà study.

Vale TC, Barbosa MT, Resende EPF, et al.

Parkinsonism & related disorders 2018; (56()):76-81 doi:10.1016/j.parkreldis.2018.06.030.

Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.

Zonneveld TP, Richard E, Vergouwen MD, et al.

The Cochrane database of systematic reviews 2018; (7()):CD007858 doi:10.1002/14651858.CD007858.pub2.

Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.

Bergkamp MI, Tuladhar AM, van der Holst HM, et al.

Parkinsonism & related disorders 2019; (61()):94-100 doi:10.1016/j.parkreldis.2018.11.010.

Vascular Parkinsonism: A Review on Management updates.

Udagedara TB, Dhananjalee Alahakoon AM, Goonaratna IK

Annals of Indian Academy of Neurology 2019; (22(1)):17-20 doi:10.4103/aian.AIAN_194_18.

Microstructural changes of normal-appearing white matter in Vascular Parkinsonism.

Salsone M, Caligiuri ME, Vescio V, et al.

Parkinsonism & related disorders 2019; (63()):60-65 doi:10.1016/j.parkreldis.2019.02.046.

The Mini-BESTest is an independent predictor of falls in Parkinson Disease.

Lopes LKR, Scianni AA, Lima LO, et al.

Brazilian journal of physical therapy 2020; (24(5)):433-440 doi:10.1016/j.bjpt.2019.07.006.

Walking on the Moon: A randomized clinical trial on the role of lower body positive pressure treadmill training in post-stroke gait impairment.

Calabrò RS, Billeri L, Andronaco VA, et al.

Journal of advanced research 2020; (21()):15-24 doi:10.1016/j.jare.2019.09.005.

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.

Amarenco P, Kim JS, Labreuche J, et al.

The New England journal of medicine 2020; (382(1)):9 doi:10.1056/NEJMoa1910355.

Outcome Evaluation of Highly Challenging Balance Training for People With Parkinson Disease: A Multicenter Effectiveness-Implementation Study.

Leavy B, Joseph C, Löfgren N, et al.

Journal of neurologic physical therapy : JNPT 2020; (44(1)):15-22 doi:10.1097/NPT.0000000000000298.

Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes.

Amarenco P, Kim JS, Labreuche J, et al.

European stroke journal 2019; (4(3)):271-280 doi:10.1177/2396987319838100.

Evaluation of the psychometric properties and clinical applications of the Timed Up and Go test in Parkinson disease: a systematic review.

Mollinedo I, Ma Cancela J

Journal of exercise rehabilitation 2020; (16(4)):302-312 doi:10.12965/jer.2040532.266.

Executive Functions Are Associated with Fall Risk but not Balance in Chronic Cerebrovascular Disease.

Tuena C, Mancuso V, Benzi IMA, et al.

Journal of clinical medicine 2020; (9(11)) doi:10.3390/jcm9113405.

The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.

Lee YH, Lee S, Chung SJ, et al.

Parkinsonism & related disorders 2021; (82()):1-6 doi:10.1016/j.parkreldis.2020.11.002.

Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson's Disease.

Isaacson JR, Brillman S, Chhabria N, Isaacson SH

Journal of Parkinson's disease 2021; (11(2)):885-889 doi:10.3233/JPD-202506.

Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review.

Mendelson SJ, Prabhakaran S

JAMA 2021; (325(11)):1088-1098 doi:10.1001/jama.2020.26867.

Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.

Boncoraglio GB, Del Giovane C, Tramacere I

Stroke 2021; (52(6)):1974-1982 doi:10.1161/STROKEAHA.120.031945.

The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders.

Kim DS, Tung GA, Akbar U, Friedman JH

Journal of the neurological sciences 2021; (428()):117581 doi:10.1016/j.jns.2021.117581.

Parkinsonism and cerebrovascular disease.

Narasimhan M, Schwartz R, Halliday G

Journal of the neurological sciences 2022; (433()):120011 doi:10.1016/j.jns.2021.120011.

Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients.

Toyoshima Y, Takahashi H, Katada S, et al.

Neuropathology : official journal of the Japanese Society of Neuropathology 2021; (41(6)):450-456 doi:10.1111/neup.12777.

Evaluation of Clinical Practice Guidelines on Fall Prevention and Management for Older Adults: A Systematic Review.

Montero-Odasso MM, Kamkar N, Pieruccini-Faria F, et al.

JAMA network open 2021; (4(12)):e2138911 doi:10.1001/jamanetworkopen.2021.38911.

Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.

Shin HW, Hong SW, Youn YC

Journal of clinical neurology (Seoul, Korea) 2022; (18(3)):259-270 doi:10.3988/jcn.2022.18.3.259.

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.

Dawson J, Béjot Y, Christensen LM, et al.

European stroke journal 2022; (7(3)):I-II doi:10.1177/23969873221100032.

Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial.

Amarenco P, Kim JS, Labreuche J, et al.

Stroke 2022; (53(11)):3260-3267 doi:10.1161/STROKEAHA.122.039728.

World guidelines for falls prevention and management for older adults: a global initiative.

Montero-Odasso M, van der Velde N, Martin FC, et al.

Age and ageing 2022; (51(9)) doi:10.1093/ageing/afac205.

Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.

Lee H, Sung YH, Hwang KH

Current medical imaging 2023; (19(9)):1041-1051 doi:10.2174/1573405619666230124142725.

Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.

Bhatia K, Ladd LM, Carr KH, et al.

Current neurology and neuroscience reports 2023; (23(5)):235-262 doi:10.1007/s11910-023-01266-2.

Vascular parkinsonism.

Holm H, Gundersen V, Dietrichs E

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2023; (143(7)) doi:10.4045/tidsskr.22.0539.

Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome.

Oh M, Oh SJ, Lee SJ, et al.

Scientific reports 2023; (13(1)):15069 doi:10.1038/s41598-023-42135-9.

Cortical excitability changes in patients of vascular parkinsonism with cognitive impairment.

Agrawal A, Bhattacharya A, Kamble N, et al.

Parkinsonism & related disorders 2023; (116()):105869 doi:10.1016/j.parkreldis.2023.105869.

Vascular cognitive impairment: When memory loss is not the biggest challenge.

van de Schraaf SA, Smit MF, Muller M, et al.

Dementia (London, England) 2024; (23(1)):152-171 doi:10.1177/14713012231214299.

The clinical and neuroimaging differences between vascular parkinsonism and Parkinson's disease: a case-control study.

George P, Roushdy T, Fathy M, et al.

BMC neurology 2024; (24(1)):56 doi:10.1186/s12883-024-03556-9.

Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial.

Lv X, Liu X, Peng Y, et al.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024; (33(5)):107647 doi:10.1016/j.jstrokecerebrovasdis.2024.107647.

Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review.

Colón-Emeric CS, McDermott CL, Lee DS, Berry SD

JAMA 2024; (331(16)):1397-1406 doi:10.1001/jama.2024.1416.

Acute Ischemic Stroke Presenting as Hemiparkinsonism: A Case Report.

Al-Sibahee E, Al-Obaidi MN, Al-Sharee A

The Neurohospitalist 2025; (15(2)):206-210 doi:10.1177/19418744241290847.

Vascular parkinsonism: an update.

Jellinger KA

Journal of neural transmission (Vienna, Austria : 1996) 2025; (132(7)):899-919 doi:10.1007/s00702-025-02960-w.

Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian Syndrome.

Xing Y, Naidu S, Martín-Bastida A, et al.

Radiology 2025; (316(1)):e240680 doi:10.1148/radiol.240680.

Clinical MRI Biomarkers to Differentiate Parkinson Disease from Its Mimics.

Haller S, He N, Schwarz S, Haacke EM

Radiology 2025; (317(1)):e242044 doi:10.1148/radiol.242044.

Early identification of stroke symptoms and risk factors using the BE FAST method: benefits of early intervention in high-risk populations.

Zang J, Bai Q, Xiong X, et al.

Frontiers in neurology 2025; (16()):1630384 doi:10.3389/fneur.2025.1630384.

Discriminating vascular parkinsonism from early-stage postural instability gait difficulty subtype dominant Parkinson's disease: a dual-task gait analysis using wearable sensors.

Li J, Li Y, Aftab K, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(2)):195 doi:10.1007/s10072-025-08795-3.

Barriers Associated with Help-Seeking for Stroke Symptoms Despite Public Awareness Campaigns: A Cross-Sectional Study.

Baig SS, Aziz M, Sara S, et al.

NeuroSci 2026; (7(3)) doi:10.3390/neurosci7030070.

Disproportionate bulbar dysfunction following small corona radiata infarction in vascular parkinsonism: A case report.

Wang HW

Medicine 2026; (105(37)):e50603 doi:10.1097/MD.0000000000050603.